At-Home Testing. 15 Minute Results — eMed Brings the Test to You.
Through an exclusive agreement with Abbott, the eMed™ digital health platform provides greater access to BinaxNOW™, the first virtually-guided, at-home COVID-19 rapid test.

In the News
Free, At-Home COVID-19 Test Kits Offered at Bucyrus, Crestline Libraries
Bucyrus Telegraph-Forum, Feb. 12, 2021
Rapid COVID-19 Tests are Being Delivered to the Doorsteps of Colorado Educators
NBC KUSA-TV, Feb. 11, 2021
“The more people that have vaccines in arms the less this disease will spread, the less we even have to worry about viral mutations”: eMed CEO
Yahoo Finance LIVE, Feb. 11, 2021
Hiram College Offering Free Home COVID Testing to Community
Record-Courier, Feb. 10, 2021
At-Home Coronavirus Testing Kits Sent To Arvada Teachers
Patch.com, Feb. 5, 2021
Colorado Gov. Delivers BinaxNOW Tests to Pueblo Teachers to Jumpstart In-Person Learning
The Pueblo Chieftain, Feb. 2, 2021
eMed is Democratizing Healthcare
eMed is democratizing healthcare by providing fast, easy, at-home healthcare solutions that are accessible to everyone. Our complete digital health solution embraces quantitative medicine and includes live video guidance using Certified Guides to ensure proper sample collection, reliable results and secure data reporting.
Introducing the First Virtually-Guided, At-Home COVID-19 Test
Abbott's BinaxNOW has a demonstrated sensitivity of 91.7% and specificity of 98.5%. Clinical trial for home tests is ongoing.
We've optimized costs to offer the lowest per test cost in the market.
Get results in minutes — without having to leave home.
The COVID-19 Testing Process
Symptomatic

Visit eMed.com to complete any required COVID-19 Testing Questionnaire.
An eMed Healthcare Partner will issue an order / prescription for your test with delivery instructions or a link for delivery tracking

Your test will be shipped within 24 hours.

Upon receipt of your test, you begin the test session at eMed.com
An eMed Certified Guide will direct you to scan the QR code located on the test and lead you through the testing process. You or your caregiver will read the test result and the guide will record the result.
Get your digital health result while still following protocols to stay safe and healthy.
We provide care guidance, following CDC guidelines.
How Our Testing Process Works
Convenient. Guided. Reliable. The way testing should be.1. Answer a few questions
Complete our CDC Questionnaire to tell us about your symptoms and exposure.
2. Get a Prescribed Order
An eMed Healthcare Partner will determine if the test is right for you and issue a prescribed order.
3. Delivery or Pick-Up
The test is shipped within 24 hours, or pick it up locally.
4. Test at Home
Have a virtual visit guided by an eMed Certified Guide.
5. Get Results in 15 Minutes
Receive follow-up healthcare instructions and a digital pass, if your COVID-19 test is negative.
Learn More
Use the links below to learn more about Abbott's BinaxNOW COVID-19 Ag Card Home Test.

What’s in the Box
The shortest route to fast results
Inside, you will find all you need to conduct a rapid COVID-19 test, authorized for use on a virtual visit with an eMed Certified Guide.



BinaxNOWTM
COVID-19 Ag Card



Newly Designed Single-Use
Extraction Reagent Bottle



Nasal Swab
The eMed Advantage
Authorized
We partner with leading manufacturers of government-authorized or approved tests.
At-Home Testing
Our digital point-of-care solution guides you through the test with live video guidance, ensuring proper test procedure and validated results.
Rapid results
Results are available within minutes of taking the test.
Digital Pass
Users who test negative receive a digital pass, enabling them to return to activities, while still following appropriate safety protocols.
- This product has not been FDA cleared or approved; but has been authorized by FDA under an EUA;
- This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; and,
- This product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.